Fibrilase, created in 2013 (Denmark), from 172 sister brands and 5164 competing brands. Fibrilase is owned by NOVOZYMES, listed on the stock exchange of Etats-Unis The ISIN, the company's International Securities Identification Number, is DK0060336014. Fibrilase belongs to the Chemicals business sector.
Investment simulator :
Portfolio valuation
NOVOZYMES
(Fibrilase)
over 5 years*
USD 61.69